iSpecimen
ISPCiSpecimen Inc. operates a technology-driven global marketplace that connects life science researchers with healthcare providers to facilitate the procurement of human biospecimens and associated data.
Earnings
Next report
Nov 5, 2026 (in 2 months)Competitors
By market cap
By revenue growth
Profile
iSpecimen Inc. operates a technology-driven global marketplace that connects life science researchers with healthcare providers to facilitate the procurement of human biospecimens and associated data. The platform automates the search, selection, and procurement process for biofluids, tissues, and living cells, aiming to accelerate medical discovery through a consolidated online experience.
iSpecimen maintains a unique position as a technology-based marketplace in a highly fragmented industry, though it faces significant competition from well-capitalized traditional biobanks and specimen providers.
FAQ
- What is iSpecimen's market cap?
- iSpecimen (ISPC) has a market capitalization of $3.5M and trades on NASDAQ.
- Who are iSpecimen's competitors?
- iSpecimen's key competitors include Azenta, Thermo Fisher Scientific, Inc., Bio-Techne Corp., and others. These companies compete in similar markets and product categories.
- Who does iSpecimen partner with?
- iSpecimen's notable partners include Centers for Disease Control and Prevention, FedEx, Amazon, and others.
- Where is iSpecimen headquartered?
- iSpecimen is headquartered in United States of America and employs approximately 53 people. It has been publicly traded since 2021.